Close
Nordic 9Nordic 9

Syncona (investor - Venture Capital)

United Kingdom synconaltd.com
See something wrong or missing? Let us know
Offices:London
Average round investment:75.65M USD
Average number per year:2.6
Distribution: 2025 (1)2024 (5)2023 (2)2022 (2)2021 (3) See the entire list
Portfolio companies: United Kingdom Beacon TherapeuticsUnited Kingdom Purespring TherapeuticsUnited Kingdom Resolution Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (15) Health services (18)
See the entire list

Showing 3 of 18 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Syncona mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Syncona

Name Criteria
United States Moore Strategic Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Sweden Summa Equity
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United Kingdom Novator Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
United Kingdom HPE Growth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States SAP.iO
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Australia Brandon Capital Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Malta Elevat3 Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Foresite Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Baleen Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Emerson Collective
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top